Background

Why anthocyanins barely reach the body.

Anthocyanins are the pigments of dark berries. How much of them can be measured in the blood after eating is surprisingly little – and research can explain why.

What bioavailability means.

Systemic bioavailability describes the proportion of an ingested substance that reaches the bloodstream unchanged.1 For anthocyanins this share is small. From millimolar concentrations in the gut, only nanomolar concentrations reach the blood. In the literature, anthocyanins are regarded as the least bioavailable class of flavonoids.2

The numbers from the studies.

Reviews mostly report values below 2 per cent for unchanged anthocyanins: below 1.8 per cent, below 1 per cent, 0.4 to 2 per cent, 0.26 to 1.8 per cent, depending on study and method.3 For individual delphinidin glycosides, 0.14 to 0.49 per cent were measured in animal studies.4 Counting the breakdown products the body forms from anthocyanins, recovery is considerably higher – around 12 per cent in one study with labelled cyanidin glucoside.5 In urine, unchanged anthocyanins are recovered only in fractions of one per cent.6

Why so little arrives.

Anthocyanins are stable in the acidic stomach but not in the neutral to slightly alkaline small intestine, where they rapidly break down into colourless degradation products. Even in the mouth, saliva can degrade part of them; delphinidin glycosides are more susceptible to this than other anthocyanins.7 A large share passes through the small intestine unchanged and is broken down by bacteria in the colon into small phenolic acids – for delphinidin, for example, gallic acid and syringic acid.8 The food matrix also plays a role: prepared with milk, the relative bioavailability of strawberry anthocyanins fell by about half in one study.9

The sugar makes the difference.

In plants, anthocyanins occur almost exclusively as glycosides, that is, with a sugar unit such as glucose, galactose, rutinose or sambubiose.10 This sugar determines stability and transport: two routes are discussed for uptake in the small intestine – transport via glucose transporters such as SGLT1 and GLUT2, or cleavage of the sugar by enzymes of the intestinal lining followed by passive uptake of the core structure.11 Which route applies and how much arrives therefore depends on which glycoside is present.

Fruit and extract.

Research observes something remarkable here: anthocyanins are often absorbed better from the whole fruit than from isolated extracts – the food matrix protects them on their way through the gut.12 Eating larger quantities of the tart, astringent maqui berry is not particularly practical in everyday life. For CELL PREVAID®, we therefore use a standardised extract that provides the constituents in concentrated form. Our formulation builds on this: we have specifically developed the complex to stabilise the sensitive delphinidin compounds and provide a reliable delivery form.

Our answer to this problem.

This is exactly where our process comes in: the sensitive delphinidin glycosides from the maqui berry are bound in a proprietary complexation process that protects the structure of the unstable molecules. Because uptake depends so strongly on the individual glycoside, we analytically determine the four delphinidin compounds in the complex individually. The complex is standardised to achieve what we consider an optimal ratio (see label information). Stability and reliability are continuously assessed and form the basis for making statements about bioavailability. Improved uptake has been demonstrated by our investigations. We are continuing to investigate the precise extent of this improvement in humans. Our research focuses on the substance’s journey to the cell.

Sources

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

This page describes research on plant compounds and experimental models. It is not a statement about any effect of CELL PREVAID® in humans.